149 related articles for article (PubMed ID: 130746)
1. Lymphocytotoxicity to tumor target cells and interference of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma.
Warnatz H; Lackner D; Eder E; Scheiffarth F; Gruhl M; Bischoff O
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Feb; 85(2):181-94. PubMed ID: 130746
[TBL] [Abstract][Full Text] [Related]
2. Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.
Nind AP; Matthews N; Pihl EA; Rolland JM; Nairn RC
Br J Cancer; 1975 Jun; 31(6):620-9. PubMed ID: 51647
[TBL] [Abstract][Full Text] [Related]
3. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
[TBL] [Abstract][Full Text] [Related]
4. Immunologic evaluation of human renal cell carcinoma. In vitro studies.
Elhilali MM; Nayak SK
Invest Urol; 1975 Jul; 13(1):60-6. PubMed ID: 49333
[TBL] [Abstract][Full Text] [Related]
5. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
Bubeník J
Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
[TBL] [Abstract][Full Text] [Related]
7. Anti-donor immune responses in prediction of transplant rejection.
Stiller CR; StC Sinclair NR; Abrahams S; McGirr D; Singh H; Howson WT; Ulan RA
N Engl J Med; 1976 Apr; 294(18):978-82. PubMed ID: 130555
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunity in patients with renal adenocarcinoma.
Bichler KH; Ax W; Tautz C
Eur Urol; 1975; 1(5):231-4. PubMed ID: 61119
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity studies in bladder and renal cell cancer.
Elhilali MM; Nayak SK
Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
[TBL] [Abstract][Full Text] [Related]
10. Mediation of immune responses to tumor antigens in vitro by immune RNA.
Kern DH; Drogemuller CR; Pilch YH
Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
Troye M; Vilien M; Pape GR; Perlmann P
Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
[TBL] [Abstract][Full Text] [Related]
12. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
[TBL] [Abstract][Full Text] [Related]
13. The significance of cytotoxicity of lymphocyte populations in coloncarcinoma patients in comparison to normal controls using a new statistical method of evaluation.
Warnatz H; Eder E; Lackner D; Hommel G
Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):128-42. PubMed ID: 906620
[TBL] [Abstract][Full Text] [Related]
14. Linoleic acid inhibition of naturally occurring lymphocytotoxicity to breast cancer-derived cells measured by a chromium-51 release assay.
Samlaska CP
J Natl Cancer Inst; 1979 Jun; 62(6):1427-33. PubMed ID: 286114
[TBL] [Abstract][Full Text] [Related]
15. Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.
Warnatz H; Scheiffarth F; Schmeissner R
Clin Exp Immunol; 1975 Aug; 21(2):250-8. PubMed ID: 1081024
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
[No Abstract] [Full Text] [Related]
17. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro.
Chu EH; Stjernswärd J; Clifford P; Klein G
J Natl Cancer Inst; 1967 Oct; 39(4):595-617. PubMed ID: 18623923
[TBL] [Abstract][Full Text] [Related]
19. Comparison of autochthonous and allogeneic breast-tumour cells in tests for lymphocyte immunity to human tumours.
Jeejeebhoy HF
Br J Cancer; 1977 Feb; 35(2):161-9. PubMed ID: 836757
[TBL] [Abstract][Full Text] [Related]
20. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
